Interferon-beta - GeneTrol Biotherapeutics
Alternative Names: HuFeronLatest Information Update: 23 Dec 2021
At a glance
- Originator GeneTrol Biotherapeutics
- Class Antineoplastics; Antivirals; Interferons; Skin disorder therapies
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Multiple sclerosis; Viral infections
Most Recent Events
- 15 Dec 2004 This profile is still in active development
- 29 Oct 2001 Preclinical development for Multiple sclerosis in USA (Unknown route)
- 29 Oct 2001 Preclinical development for Viral infections in USA (Unknown route)